Oncotarget

Research Papers:

Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma

Xinke Zhou _, Jitao Chen, Gao Yi, Min Deng, Hao Liu, Min Liang, Boyun Shi, Xin Fu, Yuqin Chen, Liangcai Chen, Zhimin He, Jian Wang and Jifang Liu

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:873-884. https://doi.org/10.18632/oncotarget.6418

Metrics: PDF 3228 views  |   HTML 4640 views  |   ?  


Abstract

Xinke Zhou1,*, Jitao Chen1,2,*, Gao Yi1,*, Min Deng2, Hao Liu2, Min Liang1, Boyun Shi1, Xin Fu3, Yuqin Chen3, Liangcai Chen1,2, Zhimin He2, Jian Wang3, Jifang Liu1,2

1Department of Respiratory Medicine and Cancer Center, The 5th Affiliated Hospital of Guangzhou Medical University, Guangzhou, PR China

2Cancer Hospital and Cancer Research Institute, Guangzhou Medical University, Guangzhou, PR China

3State Key Laboratory of Respiratory Disease, The 1st Affiliated Hospital of Guangzhou Medical University, Guangzhou, PR China

*These authors have contributed equally to this work

Correspondence to:

Jian Wang, e-mail: [email protected]

Jifang Liu, e-mail: [email protected]

Keywords: HIF-1α, metformin, metabolic reprogramming, hypoxia, hepatocellular carcinoma

Received: June 28, 2015     Accepted: November 16, 2015     Published: November 28, 2015

ABSTRACT

Overexpression of hypoxia-induced factor 1α (HIF-1α) has been shown to be involved in the development and progression of hepatocellular carcinoma (HCC). HIF-1α should therefore be a promising molecular target for the development of anti-HCC agents. Metformin, an established antidiabetic drug, has proved to also be effective in treating cancer although the precise underlying mechanisms of this activity are not fully elucidated. The aim of this study was to investigate the effects of metformin on the expression of HIF-1α and oxygen metabolism in HCC. The results showed that metformin inhibited hypoxia-induced HIF-1α accumulation and activation independent of AMP-activated protein kinase (AMPK). Moreover, this decrease in HIF-1α accumulation was accompanied by promotion of HIF-1α protein degradation. In addition, metformin significantly decreased oxygen consumption, ultimately leading to increased intracellular oxygen tension and decreased staining with the hypoxia marker pimonidazole. In vivo studies demonstrated that metformin delayed tumor growth and attenuated the expression of HIF-1α in HCC tumor xenografts. Together, these findings suggest that metformin decreases hypoxia-induced HIF-1α accumulation by actively suppressing mitochondrial oxygen consumption and enhancing cellular oxygenation ability, providing a fundamental mechanism of metformin activity against HCC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 6418